Comparison of Volumetric and 2D Measurements and Longitudinal Trajectories in the Response Assessment ofBRAFV600E-Mutant Pediatric Gliomas in the Pacific Pediatric Neuro-Oncology Consortium Clinical Trial
Open Access
- 7 March 2024
- journal article
- research article
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 45 (4) , 475-482
Abstract
BACKGROUND AND PURPOSE: Response on imaging is widely used to evaluate treatment efficacy in clinical trials of pediatric gliomas. While conventional criteria rely on 2D measurements, volumetric analysis may provide a more comprehensive response assessment. There is sparse research on the role of volumetrics in pediatric gliomas. Our purpose was to compare 2D and volumetric analysis with the assessment of neuroradiologists using the Brain Tumor Reporting and Data System (BT-RADS) in BRAF V600E-mutant pediatric gliomas. MATERIALS AND METHODS: Manual volumetric segmentations of whole and solid tumors were compared with 2D measurements in 31 participants (292 follow-up studies) in the Pacific Pediatric Neuro-Oncology Consortium 002 trial (NCT01748149). Two neuroradiologists evaluated responses using BT-RADS. Receiver operating characteristic analysis compared classification performance of 2D and volumetrics for partial response. Agreement between volumetric and 2D mathematically modeled longitudinal trajectories for 25 participants was determined using the model-estimated time to best response. RESULTS: Of 31 participants, 20 had partial responses according to BT-RADS criteria. Receiver operating characteristic curves for the classification of partial responders at the time of first detection (median = 2 months) yielded an area under the curve of 0.84 (95% CI, 0.69–0.99) for 2D area, 0.91 (95% CI, 0.80–1.00) for whole-volume, and 0.92 (95% CI, 0.82–1.00) for solid volume change. There was no significant difference in the area under the curve between 2D and solid (P = .34) or whole volume (P = .39). There was no significant correlation in model-estimated time to best response (ρ = 0.39, P >.05) between 2D and whole-volume trajectories. Eight of the 25 participants had a difference of ≥90 days in transition from partial response to stable disease between their 2D and whole-volume modeled trajectories. CONCLUSIONS: Although there was no overall difference between volumetrics and 2D in classifying partial response assessment using BT-RADS, further prospective studies will be critical to elucidate how the observed differences in tumor 2D and volumetric trajectories affect clinical decision-making and outcomes in some individuals.Keywords
Funding Information
- RSNA Research and Education Foundation
- Yale One-Year Research Fellowship Stipend
- National Center for Advancing Translational Science (KL2 TR001862)
- Botnar Research Centre for Child Health Postdoctoral Excellence Programme (#PEP-2021-1008)
- German Academic Scholarship Foundation
- American Society of Neuroradiology Fellow Award 2018
- American Society of Neuroradiology Fellow Award
This publication has 19 references indexed in Scilit:
- Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenibNeuro-Oncology, 2021
- Intermittent radiotherapy as alternative treatment for recurrent high grade glioma: a modeling study based on longitudinal tumor measurementsScientific Reports, 2021
- Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupThe Lancet Oncology, 2020
- Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade GliomasCancer Cell, 2020
- Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progressionNeuro-Oncology, 2018
- Current concepts in radiologic assessment of pediatric brain tumors during treatment, part 1Pediatric Radiology, 2018
- Management-Based Structured Reporting of Posttreatment Glioma Response With the Brain Tumor Reporting and Data SystemJournal of the American College of Radiology, 2018
- Volumetric assessment of tumor size changes in pediatric low-grade gliomas: feasibility and comparison with linear measurementsNeuroradiology, 2018
- Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab—a report from the BELOB trialNeuro-Oncology, 2017
- Intra-rater variability in low-grade glioma segmentationJournal of Neuro-Oncology, 2016